CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Biotage - BIOT CFD

173.8
0.57%
1.7
最低: 171.6
最高: 174
Market Trading Hours* (UTC) Opens on Tuesday at 08:10

Mon - Fri: 08:10 - 16:25

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 1.7
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.025632 %
Charges from borrowed part ($-1.03)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.025632%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.018813 %
Charges from borrowed part ($-0.75)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.018813%
隔夜费时间 22:00 (UTC)
最小交易量 1
货币 SEK
保证金 20%
上市交易所 Sweden
交易费 0%

*Information provided by Capital.com

Biotage AB ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 174.8
开盘价* 172.9
1 年变化* -8.08%
日范围* 171.6 - 174
52 周范围 149.80-239.40
平均交易量(10 天) 65.36K
平均交易量(3 个月) 1.86M
市值 11.51B
市盈率 48.27
流通股 65.98M
收入 1.52B
EPS 3.61
股息(收益率 %) 0.88876
贝塔 1.22
下一个财报发布日期 Feb 15, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Feb 6, 2023 173.8 0.7 0.40% 173.1 174.0 171.1
Feb 3, 2023 174.8 6.6 3.92% 168.2 175.5 166.7
Feb 2, 2023 170.2 5.9 3.59% 164.3 171.7 163.2
Feb 1, 2023 161.8 1.3 0.81% 160.5 163.7 159.9
Jan 31, 2023 159.9 1.5 0.95% 158.4 160.5 157.0
Jan 30, 2023 160.3 -0.9 -0.56% 161.2 161.8 157.5
Jan 27, 2023 161.8 2.7 1.70% 159.1 162.3 159.1
Jan 26, 2023 160.5 3.7 2.36% 156.8 162.0 156.8
Jan 25, 2023 158.5 1.8 1.15% 156.7 158.5 154.8
Jan 24, 2023 157.3 1.1 0.70% 156.2 162.7 155.5
Jan 23, 2023 156.2 1.8 1.17% 154.4 157.9 153.9
Jan 20, 2023 152.2 1.0 0.66% 151.2 153.7 147.6
Jan 19, 2023 152.7 -2.8 -1.80% 155.5 157.6 150.9
Jan 18, 2023 156.8 -7.5 -4.56% 164.3 165.4 152.6
Jan 17, 2023 172.4 1.9 1.11% 170.5 172.9 168.5
Jan 16, 2023 173.8 -1.9 -1.08% 175.7 176.1 170.0
Jan 13, 2023 175.1 -1.8 -1.02% 176.9 177.2 171.3
Jan 12, 2023 170.5 -3.5 -2.01% 174.0 175.5 169.2
Jan 11, 2023 174.0 0.5 0.29% 173.5 177.2 172.4
Jan 10, 2023 173.5 0.7 0.41% 172.8 175.6 171.4

Biotage Events

Time (UTC) Country Event
No events scheduled
View all events
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
总收入 667.912 748.147 910.896 1101.37 1092.28 1232
收入 667.912 748.147 910.896 1101.37 1092.28 1232
收入成本,共计 282.098 291.483 354.27 415.963 425.55 477
毛利 385.814 456.664 556.626 685.41 666.728 755
总营业费用 568.798 614.517 738.418 893.253 886.093 961
销售/一般/行政费用,总计 237.338 254.497 313.127 360.028 336.94 374
研究与开发 17.326 33.581 43.101 49.733 44.102 56
Depreciation / Amortization 39.795 30.241 34.032 65.132 66.449 65
利息费用(收入) - 净运营 -7.004 -8.309 -14.681 -2.41 -19.352 -16
异常费用(收入) 0 2.5 2.5
Other Operating Expenses, Total -0.755 13.024 6.069 2.307 32.404 5
营业收入 99.114 133.63 172.478 208.12 206.185 271
利息收入(费用),非经营净值 -6.713 2.63 3.811 3.949 -8.901 -12
其他,净值 0 0 0 -0.077 25.445 10
税前净收入 92.401 136.26 176.289 211.992 222.729 269
税后净收入 92.795 138.747 167.627 186.82 175.331 205
未计算非常项目前的净收益 92.795 138.747 167.627 186.82 175.331 205
净收入 92.795 138.747 167.627 186.82 175.331 205
Total Adjustments to Net Income 0.001
普通股股东可获收益 (不含非经常性项目) 92.796 138.747 167.627 186.82 175.331 205
普通股股东可获收益 (含非經常性項目) 92.796 138.747 167.627 186.82 175.331 205
摊薄净收入 92.796 138.747 167.627 186.82 175.331 205
摊薄后加权平均股 64.7144 64.7144 64.7144 65.1821 65.2085 65.4648
扣除特别项目的每股摊薄盈利 1.43393 2.14399 2.59026 2.86612 2.68877 3.13145
Dividends per Share - Common Stock Primary Issue 1.25 1.4 1.5 0 1.5 1.55
每股正常摊薄盈利 1.43393 2.14399 2.62699 2.89992 2.68877 3.17802
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
总收入 281.35 303.458 305 342 386
收入 281.35 303.458 305 342 386
收入成本,共计 103.889 121.281 122 130 145
毛利 177.461 182.177 183 212 241
总营业费用 201.972 240.943 237 281 290
销售/一般/行政费用,总计 86.447 94.618 100 123 122
研究与开发 19.389 23.065 19 29 25
Other Operating Expenses, Total -7.753 1.979 -4 -1 -2
营业收入 79.378 62.515 68 61 96
利息收入(费用),非经营净值 -2.166 -1.94 -2 4 -4
税前净收入 77.212 60.575 66 65 92
税后净收入 60.039 45.973 53 46 71
未计算非常项目前的净收益 60.039 45.973 53 46 71
净收入 60.039 45.973 53 46 71
Total Adjustments to Net Income 0.001
普通股股东可获收益 (不含非经常性项目) 60.04 45.973 53 46 71
普通股股东可获收益 (含非經常性項目) 60.04 45.973 53 46 71
摊薄净收入 60.04 45.973 53 46 71
摊薄后加权平均股 65.2304 65.2674 65.3455 66.016 65.9838
扣除特别项目的每股摊薄盈利 0.92043 0.70438 0.81107 0.6968 1.07602
Dividends per Share - Common Stock Primary Issue 0 0 0 1.55 0
每股正常摊薄盈利 0.92043 0.72531 0.81353 0.70752 1.07602
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
流动资产总额 355.98 409.252 494.438 586.569 751.615 774
现金和短期投资 128.622 174.263 177.02 185.867 371.325 311
现金等价物 128.622 174.263 177.02 185.867 371.325 311
应收账款总额,净额 130.89 128.939 173.728 212.815 207.455 207
Accounts Receivable - Trade, Net 118.348 118.191 156.042 197.651 194.018 180
Total Inventory 88.906 95.794 132.338 173.76 159.823 237
Prepaid Expenses 7.561 10.256 11.352 14.128 13.013 19
Other Current Assets, Total 0.001 -0.001 -0.001
Total Assets 695.196 757.201 1003.2 1335.69 1434.44 1992
Property/Plant/Equipment, Total - Net 45.447 45.303 48.63 112.253 103.656 128
Property/Plant/Equipment, Total - Gross 120.207 128.483 130.51 215.717 201.79 324
Accumulated Depreciation, Total -74.76 -83.18 -81.88 -103.464 -98.134 -196
Goodwill, Net 104.023 104.023 186.055 315.869 290.209 741
Intangibles, Net 116.015 118.646 192.654 260.047 250.787 313
Long Term Investments 18.645 17.838 17.368 16.614 12.254 14
Note Receivable - Long Term 1.156 0 0.003
Other Long Term Assets, Total 53.93 62.139 64.055 44.335 25.92 22
Total Current Liabilities 127.721 144.377 173.397 212.272 217.364 313
Accounts Payable 38.133 47.457 54.764 41.461 51.236 56
Payable/Accrued -0.001 0.001
Accrued Expenses 47.103 50.561 60.411 69.334 58.479
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 21.231 21.214 23
Other Current Liabilities, Total 42.486 46.359 58.222 80.245 86.435 234
Total Liabilities 131.958 148.59 301.023 460.184 444.403 621
Total Long Term Debt 0 0 109.4 147.647 140.677 180
Deferred Income Tax 1.759 1.621 14.78 28.884 32.838 73
Other Liabilities, Total 2.478 2.592 3.446 71.381 53.524 55
Total Equity 563.238 608.611 702.18 875.503 990.038 1371
Common Stock 89.953 89.953 89.953 90.63 90.969 92
Retained Earnings (Accumulated Deficit) 557.223 615.077 692.104 781.121 956.114 1063
Other Equity, Total -83.938 -96.419 -79.877 3.752 -116.547 -50
Total Liabilities & Shareholders’ Equity 695.196 757.201 1003.2 1335.69 1434.44 1992
Total Common Shares Outstanding 64.7144 64.7144 64.7144 64.7144 65.2018 65.9838
Long Term Debt 109.4 109.55 110 150
Capital Lease Obligations 38.097 30.677 30
Additional Paid-In Capital 59.502 266
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
流动资产总额 851.273 694.254 784 774 842
现金和短期投资 422.068 278.552 359 311 349
现金等价物 422.068 278.552 359 311 349
应收账款总额,净额 237.214 221.377 217 226 249
Accounts Receivable - Trade, Net 204.607 191.724 181 226 216
Total Inventory 191.992 194.326 208 237 244
Other Current Assets, Total -0.001 -0.001
Total Assets 1575.81 1409.61 1503 1992 2056
Property/Plant/Equipment, Total - Net 126.05 125.751 124 128 126
Goodwill, Net 302.381 297.524 304 741 746
Intangibles, Net 259.79 257.747 257 313 309
Long Term Investments 12.263 12.224 12 14 15
Other Long Term Assets, Total 24.051 22.115 22 22 18
Total Current Liabilities 246.435 263.719 289 313 298
Accounts Payable 53.503 46.03 54 56 43
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 22.653 23.289 24 23 23
Other Current Liabilities, Total 170.279 194.4 211 234 232
Total Liabilities 493.496 390.115 413 621 601
Total Long Term Debt 153.626 40.861 37 180 175
Long Term Debt 110 0 0 150 150
Capital Lease Obligations 43.626 40.861 37 30 25
Deferred Income Tax 36.325 36.86 37 73 72
Other Liabilities, Total 57.11 48.675 50 55 56
Total Equity 1082.31 1019.5 1090 1371 1455
Common Stock 90.969 90.969 91 92 92
Additional Paid-In Capital 60.137 61.239 64 266 269
Retained Earnings (Accumulated Deficit) 1016.15 964.324 1017 1063 1134
Other Equity, Total -84.948 -97.032 -82 -50 -40
Total Liabilities & Shareholders’ Equity 1575.81 1409.61 1503 1992 2056
Total Common Shares Outstanding 65.2018 65.2018 65.2018 65.9838 65.9838
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
净收入/起跑线 92.401 136.26 176.289 211.992 222.729 269
经营活动产生的现金 139.072 168.932 155.005 211.807 279.047 353
经营活动产生的现金 43.836 34.225 39.412 74.372 73.904 75
非现金物品 -1.187 1.991 -11.727 2.129 -11.661 4
Cash Taxes Paid 5.363 5.091 9.314 9.925 15.083 16
已付现金利息 0.023 0.002 1.738 2.86 3.339 3
营运资金的变化 4.022 -3.544 -48.969 -76.686 -5.925 5
投资活动产生的现金 -67.726 -36.903 -178.411 -85.676 -61.32 -341
资本支出 -47.54 -37.804 -47.158 -45.454 -60.941 -56
其他投资现金流量项目,总计 -20.186 0.901 -131.253 -40.222 -0.379 -285
融资活动产生的现金 -81.152 -81.053 19.342 -119.205 -22.723 -82
Total Cash Dividends Paid -80.893 -80.893 -90.6 -97.803 0 -98
债务的发行(退还),净额 -0.259 -0.16 109.942 -21.402 -22.723 16
外汇效应 3.544 -5.336 6.821 1.921 -9.547 9
现金净变化 -6.262 45.64 2.757 8.847 185.457 -61
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 77.212 137.787 204 269 92
Cash From Operating Activities 67.62 159.904 249 353 57
Cash From Operating Activities 17.133 35.656 54 75 23
Non-Cash Items -1.912 -2.579 -5 4 5
Cash Taxes Paid 4.569 8.686 14 16 15
Changes in Working Capital -24.813 -10.96 -4 5 -63
Cash From Investing Activities -18.266 -34.637 -45 -341 -14
Capital Expenditures -18.266 -34.137 -44 -56 -14
Other Investing Cash Flow Items, Total 0 -0.5 -1 -285 0
Cash From Financing Activities -5.17 -223.759 -227 -82 -6
Issuance (Retirement) of Debt, Net -5.17 -125.956 -129 16 -6
Foreign Exchange Effects 6.559 5.719 10 9 2
Net Change in Cash 50.743 -92.773 -13 -61 39
Total Cash Dividends Paid -97.803 -98 -98 0
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
SEB Investment Management AB Investment Advisor 7.55 4981775 -6598 2022-12-31 LOW
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 6.84 4513290 -1505315 2022-12-31 LOW
Invesco Advisers, Inc. Investment Advisor 5.75 3794067 -41121 2022-12-31 LOW
ODIN Forvaltning AS Investment Advisor 4.5466 3000000 0 2022-12-31 LOW
Didner & Gerge Fonder AB Investment Advisor 3.8037 2509857 1528969 2022-12-31 LOW
Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 3.6075 2380357 17122 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.39 2236850 52787 2022-12-31 LOW
Lannebo Fonder AB Investment Advisor/Hedge Fund 3.2803 2164438 0 2022-12-31 LOW
Tredje AP Fonden Pension Fund 3.1 2045497 310124 2022-12-31 LOW
Första AP-Fonden Pension Fund 2.3926 1578713 1578713 2022-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.31 1524225 -6599 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.86 1227298 59385 2022-12-31 LOW
TIN Fonder Investment Advisor 1.53 1009552 -10412 2022-12-31 MED
Montanaro Asset Management Limited Investment Advisor 1.37 903978 219232 2022-12-31 LOW
M & G Investment Management Ltd. Investment Advisor 1.25 824797 0 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.14 752215 -39590 2022-09-30 LOW
Goldman Sachs Asset Management, L.P. Investment Advisor 1.0636 701784 -154 2022-11-30 LOW
DNCA Investments Investment Advisor 0.9396 620000 -50224 2022-12-31 LOW
Danske Bank Asset Management Investment Advisor 0.9353 617175 0 2023-01-31 LOW
Nordea Funds Oy Investment Advisor 0.9048 597007 -5298 2022-12-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group
+485000+

交易者

65000+

每月活跃客户

$48000000+

每月投资额

$28000000+

每月提取金额

交易計算器

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

貿易佣金
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
杠杆
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Biotage Company profile

关于 Biotage AB

Biotage AB是一家总部设在瑞典的公司,在生命科学领域开发和销售系统、消耗品和服务。 其客户包括制药和生物技术公司、食品行业的公司和学术机构。 公司在三个领域提供系统和服务:分析化学、有机化学和工业树脂。 百泰在分析化学领域提供的产品包括从各种类型的样品中提取特定物质的相关应用的消耗品。 公司的有机化学产品包括基于小分子和多肽的药物开发产品,其工业树脂产品由聚合物树脂和研究服务组成,导致聚合物材料的开发和制造。 截至2013年12月31日,该公司在全球范围内经营着12家全资子公司。

Industry: Medical Diagnostic & Testing Equipment

Vimpelgatan 5
UPPSALA
UPPSALA 753 18
SE

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

75.13 Price
+2.360% 1D Chg, %
多头隔夜费 -0.0244%
空头隔夜费 0.0086%
隔夜费时间 22:00 (UTC)
价差 0.03

BTC/USD

22,912.00 Price
-0.100% 1D Chg, %
多头隔夜费 -0.0500%
空头隔夜费 0.0140%
隔夜费时间 22:00 (UTC)
价差 60.00

Natural Gas

2.52 Price
+4.160% 1D Chg, %
多头隔夜费 -0.1164%
空头隔夜费 0.0824%
隔夜费时间 22:00 (UTC)
价差 0.005

XRP/USD

0.39 Price
-1.250% 1D Chg, %
多头隔夜费 -0.0500%
空头隔夜费 0.0140%
隔夜费时间 22:00 (UTC)
价差 0.00354

还在找一位您可以信任的经纪商吗?

加入成为全球485,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易